---
title: "Beigene's \"BeYueDa\" completes its first sale in Beijing"
description: "China National Pharmaceutical Group announced that as the preferred distributor for BeiGene's new product \"BaYueDa\" in Beijing, it successfully completed the first order delivery for BeiGene yesterday"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/272626786.md"
published_at: "2026-01-15T01:29:40.000Z"
---

# Beigene's "BeYueDa" completes its first sale in Beijing

> China National Pharmaceutical Group announced that as the preferred distributor for BeiGene's new product "BaYueDa" in Beijing, it successfully completed the first order delivery for BeiGene yesterday (14th). The medication arrived at China National Pharmaceutical Group's logistics in the afternoon of the same day, and with the cooperation and coordination of relevant departments such as the procurement center, Beijing direct sales center, and China National Pharmaceutical Group logistics, it was delivered to the designated DTP pharmacy within 3 hours after arrival

China National Pharmaceutical Group Corporation (600511.SH) announced that, as the preferred distributor for BeiGene (06160.HK) for its new product "Baiyueda," it successfully completed the first delivery for BeiGene yesterday (14th). The medication arrived at China National Pharmaceutical Group's logistics in the afternoon yesterday and, with the cooperation and coordination of relevant departments such as the procurement center, Beijing direct sales center, and China National Pharmaceutical Group logistics, was delivered to the designated DTP pharmacy within 3 hours after arrival

### Related Stocks

- [688235.CN - BeOne Medicines](https://longbridge.com/en/quote/688235.CN.md)
- [BGNE.US - Beigene](https://longbridge.com/en/quote/BGNE.US.md)
- [06160.HK - BEONE MEDICINES](https://longbridge.com/en/quote/06160.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 百济神州 (6160.HK)：区间震荡拉锯，资金谨慎反复，医药板块新规前博弈趋于复杂 | 2 月 3 日收盘，百济神州全天波动显著，盘中高开回踩。资金虽然阶段性活跃，支撑了小幅反弹，但整体走势后继乏力。当前医药板块大势较为温和，大盘反弹引来部分长线资金试探入场，主力操作表现明显犹豫与反复，全日节奏以震荡偏强为主。 市场近期关注  | [Link](https://longbridge.com/en/news/274627352.md) |
| 百济神州 (6160.HK)：区间震荡拉锯，资金谨慎反复，医药板块新规前博弈趋于复杂 | 2 月 3 日收盘，百济神州全天波动显著，盘中高开回踩。资金虽然阶段性活跃，支撑了小幅反弹，但整体走势后继乏力。当前医药板块大势较为温和，大盘反弹引来部分长线资金试探入场，主力操作表现明显犹豫与反复，全日节奏以震荡偏强为主。 市场近期关注  | [Link](https://longbridge.com/en/news/274633564.md) |
| 为什么 Instacart 的股票今天上涨 | 公司的丰富选择、快速的配送选项以及更具竞争力的价格正在受到消费者的欢迎 | [Link](https://longbridge.com/en/news/275955170.md) |
| 百济神州 (6160.HK)：区间震荡拉锯，资金谨慎反复，医药板块新规前博弈趋于复杂 | 2 月 3 日收盘，百济神州全天波动显著，盘中高开回踩。资金虽然阶段性活跃，支撑了小幅反弹，但整体走势后继乏力。当前医药板块大势较为温和，大盘反弹引来部分长线资金试探入场，主力操作表现明显犹豫与反复，全日节奏以震荡偏强为主。 市场近期关注  | [Link](https://longbridge.com/en/news/274628090.md) |
| 百济神州 (6160.HK)：区间震荡拉锯，资金谨慎反复，医药板块新规前博弈趋于复杂 | 2 月 3 日收盘，百济神州全天波动显著，盘中高开回踩。资金虽然阶段性活跃，支撑了小幅反弹，但整体走势后继乏力。当前医药板块大势较为温和，大盘反弹引来部分长线资金试探入场，主力操作表现明显犹豫与反复，全日节奏以震荡偏强为主。 市场近期关注  | [Link](https://longbridge.com/en/news/274632359.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
